-
2024-514695-41-00
5
2025-10-17
Ulcerative Colitis
-
2025-520624-25-00
10
2025-09-19
Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
-
2024-518502-40-00
9
2025-07-28
Immune Thrombocytopenia
-
2024-511458-32-00
5
2025-06-15
Ulcerative colitis
-
2024-514732-24-00
6
2025-04-28
Juvenile idiopathic arthritis
-
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
-
2024-515451-38-00
5
2025-02-27
Primary Immune thrombocytopenia (ITP)
-
2023-504773-20-00
5
2024-08-01
Active Chronic Pouchitis
-
2023-507067-19-00
4
2024-05-15
Autoimmune Cytopenias (warm autoimmune hemolytic anemia [wAIHA], cold
-
2023-503290-38-00
4
2023-09-05
Bronchiectasis
-
2023-509810-13-00
4
2023-05-13
Acute Lymphoblastic Leukemia (ALL)
-
2022-502503-30-00
5
2022-12-15
Acute lymphoblastic leukemia
-
2024-518223-29-00
4
2020-03-10
Advanced or metastatic untreated EGFR mutation positive NSCLC
-
2025-523079-44-00
5
2026-04-15
Turner Syndrome (TS)
-
2025-523091-23-00
4
2026-03-24
Peripheral anti-MAG neuropathy, waldenstrom macroglobulinemia, margina
-
2025-523015-11-00
5
2026-03-18
Pericarditis
-
2024-518167-35-01
4
2025-12-19
Patients with Metastatic Osteosarcoma
-
2025-521692-31-00
5
2025-12-19
Chronic Primary Immune Thrombocytopenia
-
2024-518465-10-00
4
2025-12-12
Multiple Autoimmune Glomerular Diseases
-
2024-519960-42-00
4
2025-12-11
PIK3CA-Related Overgrowth Spectrum (PROS)
-
2024-514401-54-00
5
2025-11-13
Chronic Primary Immune Thrombocytopenia
-
2024-519345-30-00
5
2025-11-12
IgA nephropathy
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2024-513613-12-00
9
2025-09-18
Part A: Healthy volunteers (Part A is not applicable to the EU; for in